Alcohol consumption and risk of inflammatory bowel disease among three prospective US cohorts. Issue 2 (8th December 2021)
- Record Type:
- Journal Article
- Title:
- Alcohol consumption and risk of inflammatory bowel disease among three prospective US cohorts. Issue 2 (8th December 2021)
- Main Title:
- Alcohol consumption and risk of inflammatory bowel disease among three prospective US cohorts
- Authors:
- Casey, Kevin
Lopes, Emily W.
Niccum, Blake
Burke, Kristin
Ananthakrishnan, Ashwin N.
Lochhead, Paul
Richter, James M.
Chan, Andrew T.
Khalili, Hamed - Abstract:
- Summary: Background and aims: There are limited data on alcohol dose and types and risk of Crohn's Disease (CD) and Ulcerative Colitis (UC). We therefore sought to comprehensively examine the association between alcohol consumption and risk of CD and UC. Methods: We conducted a prospective cohort study of 237, 835 participants from the Nurses' Health Study, Nurses' Health Study II, and Health Professional Follow‐Up Study. Alcohol consumption was obtained through questionnaires submitted every four years; additional covariates were obtained at two or four‐year intervals. Cases were confirmed independently by two physicians through medical record review. We used Cox proportional hazards regression to estimate age and multivariable‐adjusted hazards ratios and 95% confidence intervals. Results: Across 5, 170, 474 person‐years of follow‐up, 370 cases of CD and 486 cases of UC were documented. Increased consumption of alcohol intake was not associated with CD (Ptrend = 0.455) or UC (Ptrend = 0.745). Compared to non‐users, the MV‐adjusted HRs for 15.0 + g/day of alcohol intake group were 0.84 (95% CI 0.56, 1.24) for CD and 1.08 (95% CI 0.77, 1.51) for UC. In analyses of alcohol subtypes, we observed that only moderate consumption of beer (>1‐4 servings/week) was marginally associated with reduced risk of CD, while consumption of >4 servings/week of liquor was associated with an increased risk of UC. Conclusion: This prospective study did not identify a relationship between overallSummary: Background and aims: There are limited data on alcohol dose and types and risk of Crohn's Disease (CD) and Ulcerative Colitis (UC). We therefore sought to comprehensively examine the association between alcohol consumption and risk of CD and UC. Methods: We conducted a prospective cohort study of 237, 835 participants from the Nurses' Health Study, Nurses' Health Study II, and Health Professional Follow‐Up Study. Alcohol consumption was obtained through questionnaires submitted every four years; additional covariates were obtained at two or four‐year intervals. Cases were confirmed independently by two physicians through medical record review. We used Cox proportional hazards regression to estimate age and multivariable‐adjusted hazards ratios and 95% confidence intervals. Results: Across 5, 170, 474 person‐years of follow‐up, 370 cases of CD and 486 cases of UC were documented. Increased consumption of alcohol intake was not associated with CD (Ptrend = 0.455) or UC (Ptrend = 0.745). Compared to non‐users, the MV‐adjusted HRs for 15.0 + g/day of alcohol intake group were 0.84 (95% CI 0.56, 1.24) for CD and 1.08 (95% CI 0.77, 1.51) for UC. In analyses of alcohol subtypes, we observed that only moderate consumption of beer (>1‐4 servings/week) was marginally associated with reduced risk of CD, while consumption of >4 servings/week of liquor was associated with an increased risk of UC. Conclusion: This prospective study did not identify a relationship between overall alcohol consumption and risk of CD or UC. Our suggestive associations between alcohol types and risk of CD and UC deserve additional investigation. Abstract : Among three prospective cohorts, there was no association between alcohol consumption and risk of Crohn's disease or ulcerative colitis. The risk of CD was 0.86 (95% CI 0.67, 1.11) for 0.1–4.9 g/day, 0.81 (95% CI 0.59, 1.10) for‐5.0–14.9 g/day, and 0.84 (95% CI 0.56, 1.24) for 15.0 + g/day. The risk of UC was 0.99 (95% CI 0.79, 1.24) for 0.1–4.9 g/day, 0.94 (95% CI 0.71, 1.24) for 5.0–14.9 g/day, and 1.08 (95% CI 0.77, 1.51) for 15.0 g+/day. … (more)
- Is Part Of:
- Alimentary pharmacology & therapeutics. Volume 55:Issue 2(2022)
- Journal:
- Alimentary pharmacology & therapeutics
- Issue:
- Volume 55:Issue 2(2022)
- Issue Display:
- Volume 55, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 55
- Issue:
- 2
- Issue Sort Value:
- 2022-0055-0002-0000
- Page Start:
- 225
- Page End:
- 233
- Publication Date:
- 2021-12-08
- Subjects:
- Alcohol -- beer -- Crohn's disease -- liquor -- ulcerative colitis -- wine
Digestive organs -- Diseases -- Treatment -- Periodicals
Digestive organs -- Effect of drugs on -- Periodicals
Gastrointestinal system -- Diseases -- Treatment -- Periodicals
Gastrointestinal system -- Effect of drugs on -- Periodicals
615.73 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2036 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/apt.16731 ↗
- Languages:
- English
- ISSNs:
- 0269-2813
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0787.886000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 20554.xml